Parent Perspectives on Nirsevimab for Their Newborn.
Hinderstein S, Aragona E, Loyal J. Parent Perspectives on Nirsevimab for Their Newborn. Pediatrics 2024, 154 PMID: 39587878, DOI: 10.1542/peds.2024-067532.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntibodies, Monoclonal, HumanizedBronchiolitisFemaleHealth Knowledge, Attitudes, PracticeHumansInfant, NewbornInterviews as TopicMaleParentsRespiratory Syncytial Virus InfectionsTrustConceptsRespiratory syncytial virusRespiratory syncytial virus prophylaxisRSV disease severityMaternal RSV vaccineHealth Belief ModelHealthy newbornsRSV vaccineRSV infectionParents of newbornsNewborn unitSyncytial virusNirsevimabSide effectsNewbornsBelief ModelPediatric hospitalMonoclonal antibodiesDisease severityCOVID-19 vaccineProphylaxisVaccineIncreasing overall awarenessInfantsPediatrician's recommendationPositively influence decisionEarly Experiences With Nirsevimab: Perspectives From Newborn Hospitalists.
Aragona E, Joshi N, Birnie K, Lysouvakon P, Basuray R. Early Experiences With Nirsevimab: Perspectives From Newborn Hospitalists. Hospital Pediatrics 2024, 14: e170-e172. PMID: 38115681, DOI: 10.1542/hpeds.2023-007639.Peer-Reviewed Original Research